öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÒ¶¹úÁ¼
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º733

ËùÊôԺУ£ºÄþ²¨´óѧ
ËùÊôԺϵ£ºÒ½Ñ§Ôº
Ö°³Æ£ºÖ÷ÈÎҽʦ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿Æѧ
Ñо¿ÁìÓò£º Ïû»¯µÀÔç°©ÄÚ¾µÕïÖΡ¢Ïû»¯ÄÚ¾µÐ¼¼ÊõÓ¦ÓÃ
Ñо¿ÁìÓò£º Ïû»¯µÀÔç°©ÄÚ¾µÕïÖΡ¢Ïû»¯ÄÚ¾µÐ¼¼ÊõÓ¦Óà [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºndfyygl@163.com
ͨѶµØÖ·£ºÄþ²¨Êн­±±ÇøÈËÃñ·247ºÅ£¬Äþ²¨´óѧҽѧԺ¸½ÊôÒ½ÔºÏû»¯ÄÚ¿Æ


¸öÈ˼òÊö :
1987Äê8Ô±ÏÒµÓÚÕã½­Ò½¿Æ´óѧҽѧϵ£¬ÏÖÈÎÄþ²¨´óѧҽѧԺ¸½ÊôÒ½ÔºÔº³¤ÖúÀí¡¢Ïû»¯²¡ÕïÖÎÖÐÐÄÖ÷ÈΡ¢Ïû»¯ÄÚ¿ÆÖ÷ÈΣ»³¤ÆÚÔÚÁÙ´²Ò»Ïß¹¤×÷£¬Éó¤Ïû»¯ÏµÒÉÄÑΣÖز¡ÕïÖκÍÏû»¯ÄÚ¾µÐ¼¼ÊõÓ¦Óã¬ÓÈÆäÔÚÏû»¯µÀÔç°©µÄÄÚ¾µÕïÖΡ¢Ïû»¯µÀ³öѪµÄ·ÇÊÖÊõÕïÖΡ¢µ¨Òȼ²²¡µÄÄÚ¾µÕïÖΡ¢Ïû»¯µÀÏÁÕ­¼°êÚÃÅʧ³Ú»ºÖ¢µÄÄÚ¾µÖÎÁƵÈÁìÓò´¦Ê¡ÄÚÁìÏÈ¡¢¹úÄÚÏȽøˮƽ£¬¶à´ÎÊÜÑûÔÚ¹úÄÚÍâѧÊõ»áÒéÉÏ×÷ÄÚ¾µÊÖÊõÑÝʾ£»×¢ÖØѧ¿Æ½¨ÉèÓëÄêÇáÒ½ÉúÅàÑø£¬½üÄêÀ´´øÁìѧ¿ÆÏȺó»ñµÃÕã½­Ê¡ÇøÓòר²¡ÖÐÐÄ£¨Õ㶫Ïû»¯ÄÚ¿Æ£©¡¢Äþ²¨ÊÐÊм¶Ò½ÔºÁÙ´²ÌØÉ«Öصãר¿Æ£¨Ïû»¯µÀÔç°©ÄÚ¾µÕïÖΣ©¡¢Äþ²¨ÊÐҽѧÖصãѧ¿Æ(賦²¡Ñ§)£¬±»ÖлªÒ½Ñ§»áÊÚÓè¡°Öйúʳ¹ÜθÇúÕž²ÂöÓ²»¯ÖÎÁƼ¼ÊõÅàѵ»ùµØ¡±¡°È«¹úÄÚ¾µÔç°©¹æ·¶»¯¼¼ÄÜÅàѵ»ùµØ¡±¡°ÖйúÄÚ¾µ½«²Å¹¤³ÌÅàѵÖÐÐÄ¡±£¬ÄêÍê³ÉÄÚ¾µÖÎÁÆ2500¶àÀý´Î£¬Ã¿ÄêÖ÷³Ö¾Ù°ì¹ú¼Ò¼¶¼Ì½Ì°àÒ»ÆÚ¡¢ÄÚ¾µÕïÖÎм¼ÊõÅàѵ°àÊýÆÚ£»ÔøÏȺó»ñµÃµÚÒ»ÅúÄþ²¨ÊÐÓÅÐãÖÐÇàÄêÎÀÉú¼¼ÊõÈ˲Å¡¢µÚ¶þ½ìÄþ²¨Êа×Çó¶÷ʽҽÎñ¹¤×÷Õß¡¢Äþ²¨ÊÐÎåÒ»ÀͶ¯½±Õ¡¢2016Äê»ñµÚÊ®½ìÖйúҽʦ½±¡£


¿ÆÑй¤×÷ :
1¡¢Low expression of hsa_circ_** in human gastric cancer and its clinical significances[J]. Tumour Biology, 2017, 39(6):**04175. (IF:3.65)

2¡¢Decreased expression of hsa_circ_** in human gastric cancer and its clinical significances[J]. Tumour Biology, 2017, 39(4):**99125. (IF:3.65)

3¡¢Identification of tissue-specific circRNA hsa_circ_** as an indicatorn for human gastric cancer[J]. Int J Clin Exp Pathol, 201710(3):3151-3156. (IF:1.70)

4¡¢Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis[J]. Scientific Reports, 2016,10:1038. (IF:4.26)

5¡¢The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis[J]. PLoS ONE,2016,11(11): e**.(IF:2.806)

6¡¢Continuous Renal Replacement Therapy in Successful Treatment ofa Patient With Hyperlipidemic Acute Pancreatitis[J].Ther Apher Dial,2015,19(5):518-521. (IF:1.705)

7¡¢Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer[J].Tumor Biology,2015,3(36): **30380. (IF:2.84)

8¡¢ÄÚ¾µÏÂÍƽøʽ·ÅÉä×´ÇпªÊõÖÎÁÆÁ¼ÐÔʳ¹ÜÏÁÕ­µÄÁÆЧ¹Û²ì£¨º¬ÊÓƵ£© ÖлªÏû»¯ÄÚ¾µÔÓÖ¾£¬2016,33(01):37-39.

9¡¢Stathmin1µ°°×ÔÚθ°©Ñݱä¹ý³ÌÖеıí´ïÒâÒå¼°ÓëÓÄÃÅÂݸ˾ú¸ÐȾ¹Øϵ. Õã½­ÁÙ´²Ò½Ñ§,2015, 8(17): 1385-1386

10¡¢Î¸ð¤Ä¤»î¼ìµÍ¼¶±ðÉÏƤÄÚÁö±äµÄת¹é¼°ÆäÓëÔçÆÚθ°©µÄ¹Øϵ¡£Õ㽭ҽѧ£¬2014,2: 134-136¡£

11¡¢IncRNA£ºÖ×Áö·Ö×ÓÕï¶ÏÖеÄÒ»¿ÅÐÂÐÇ¡£ÖйúÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ±¨¡£2014,3£¨30£©: 233-240

12¡¢ÄÚ¾µð¤Ä¤Ï°þÀëÊõÔÚÖÎÁÆθÉÏƤÄÚÁö±äÖеÄÓ¦ÓÃÓëÆÀ¼Û¡£Î¸³¦²¡Ñ§ºÍ¸Î²¡Ñ§ÔÓÖ¾£¬2012,4£¨21£©£º 319-321

13¡¢ÄÚ¾µð¤Ä¤Ï°þÀëÊõÔÚÀÏÄêÔçÆÚθ°©ÖÎÁÆÖеÄÓ¦Óá£ÏÖ´úʵÓÃҽѧ£¬2010£¬ 10£¨22£©£º 1106-1107

Õ㽭ʡҽѧ»áÏû»¯ÄÚ¾µÑ§·Ö»á³£ÎñίԱ

Õ㽭ʡʳ¹ÜθÇúÕž²ÂöÕïÖÎѧ×鸱×鳤

Õã½­Ê¡³¬ÉùÄÚ¾µÑ§×éίԱ

Õã½­Ê¡Ïû»¯µÀÔ簩ѧ×éίԱ

Õã½­Ê¡¿µ¸´Ò½Ñ§»áθ³¦ÓªÑøöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±Ö÷ÈÎίԱ

Õã½­Ê¡¿¹°©Ð­»á´ó³¦°©öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á´ó³¦ÄÚ¾µÑ§×éίԱ

Äþ²¨ÊÐҽѧ»áÀíÊÂ

Äþ²¨ÊÐҽѧ»áÏû»¯ÄÚ¾µÑ§·Ö»áÖ÷ÈÎίԱ

Äþ²¨ÊÐҽѧ»áÏû»¯²¡Ñ§·Ö»áίԱ

Äþ²¨ÊÐÏû»¯µÀÔç°©ÕïÖÎЭ×÷×é×鳤

ÖйúÒ½ÁÆÆ÷еÐÐҵЭ»áÏû»¯ÄÚ¾µ´´Ð·¢Õ¹·Ö»áÀíÊÂ
1¡¢Î¸³¦Ôç°©ÌåÍâÕï¶Ï²úÆ·Ñз¢£¬Äþ²¨Êд´ÐÂÍŶÓÏîÄ¿£¨2017C110019£©£¨ÅÅÃûµÚ¶þ£¬¾­·Ñ100Íò£©

2¡¢ÉÏÏû»¯µÀÔç°©ÄÚ¾µ¾«²é¼¼ÊõÍƹ㼰Æä·ÀÖÎÌåϵµÄ½¨Á¢£¬Õã½­Ê¡¹«Òæ¼¼ÊõÓ¦ÓÃÑо¿¼Æ»®ÏîÄ¿£¨2017C35004£©£¨¾­·Ñ10Íò£©

3¡¢³¤Á´·Ç±àÂëRNA×÷Ϊθ°©ÔçÆÚÕï¶Ï±êÖ¾ÎïµÄ¿ÉÐÐÐÔÑо¿£¬Äþ²¨ÊÐ×ÔÈ»»ù½ðÏîÄ¿£¨2013A610206£©£¬ÒÑÍê³É

4¡¢Î¸ÉÏƤÄÚÁö±ä¾­ÄÚ¾µÇгýÊõÇ°ºó²¡Àí¶Ô±ÈÓëÁÙ´²¡¢ÄÚ¾µÌØÕ÷Ïà¹ØÐÔÑо¿£¬Äþ²¨ÊÐҽѧ¿Æ¼¼¼Æ»®ÏîÄ¿£¨2013A18£©£¬ÒÑÍê³É

5¡¢ÄÚ¾µð¤Ä¤Ï°þÀëÊõÖÎÁÆÔçÆÚθ°©¼°°©Ç°²¡±äµÄÑо¿£¬ Äþ²¨ÊÐҽѧ¿Æ¼¼¼Æ»®ÏîÄ¿£¨2010A07£©£¬ÒÑÍê³É

6¡¢ÄÚ¾µÏÂÕïÖδó³¦Æ½Ì¹ÐͲ¡±äµÄÁÙ´²Ñо¿£¬ Äþ²¨ÊÐҽѧ¿Æ¼¼¼Æ»®ÏîÄ¿£¨**£©£¬ÒÑÍê³É

7¡¢ÖÐÐÄÌåÒì³£ÔÚθ°©ÔçÆÚ·¢Éú·¢Õ¹ÖеÄÒâÒ壬 Õã½­Ê¡Ò½Ò©ÎÀÉú¿Æ¼¼¼Æ»®ÏîÄ¿£¨ 2007A177£©£¬ÒÑÍê³É

1¡¢ERCPÕïÖε¨Òȼ²²¡£¬Õã½­Ê¡Ò½Ò©ÎÀÉú¿Æ¼¼´´Ð½±ÈýµÈ½±£¬2008Äê

2¡¢Î¸ÒºÖÐ΢СRNAµÄ·ÖÎö¼°ÆäÔÚθ°©Õï¶ÏÖеļÛÖµÑо¿£¬ Õã½­Ê¡Ò½Ò©ÎÀÉú¿Æ¼¼½±¶þµÈ½± 2016Ä꣨ÅÅÃûµÚ¶þ£©

3¡¢Ê×½ìÈ«¹ú ¡°º£²©µ¶ÊÖÊõÊÓƵ´óÈü¡± ÈýµÈ½±£¬2015Äê

4¡¢2013 ¡°°¢Ë¹Àû¿µ±­¡± È«¹úÄÚ¾µÕ¹²¥.Õã½­ ÓÅÐã×÷Æ·Ò»µÈ½±